Also categorized in BoardMoves:
Time Inc. Appoints Griffin CEO
x hide permanently

Humacyte Expands Board of Directors with Appointment of Diane Seimetz, Ph.D.


Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable bioengineered human tissue at commercial scale, today announced the appointment of Diane Seimetz, Ph.D., to its board of directors...

Mentions: Nasdaq Board Board of Directors